Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor Microenvironment

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing…

China Dynamics Appoints International Advisors

Accelerates Expansion into Global Market   HONG KONG SAR - Media OutReach - 28 January 2021 - China…

XpresSpa Group Supports Airlines to Meet Dutch Travel Restrictions; XpresCheck to Pilot Rapid COVID-19 Antigen Tests for Transatlantic Flights

XpresCheck testing facilities support new rapid testing requirements for select flights with United, Delta and…

83% of Oracle Database Licensees Cite Vendor Support Costs as Excessive or Too Much; Burdensome Updates and Poor Vendor Support Among Top Challenges in Survey

Oracle Database licensees may consider using third-party support to provide better, more cost-efficient support and…

CyberLink FaceMe® Tops Facial Recognition Vendor Test

With its facial recognition solution FaceMe®, CyberLink ranks first1 among global vendors in the latest…

Tufin Expands its Footprint in India With New Hires

BOSTON--(BUSINESS WIRE)--$TUFN #automation--Tufin® (NYSE: TUFN), a company pioneering a policy-centric approach to security and IT…

BAI Announces 2020 Global Innovation Award Finalists

CHICAGO--(BUSINESS WIRE)--BAI announced the finalists for the 2020 BAI Global Innovation Awards, the industry’s prestigious…

Options Appoints former Quantbot Founder and CEO Michael Botlo To Board

NEW YORK & LONDON & HONG KONG & TORONTO & GENEVA--(BUSINESS WIRE)--Options, the leading provider…

Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy

Mobocertinib, an oral targeted therapy, demonstrated clinically meaningful responses, with a confirmed objective response rate…

Ultimovacs Announces NIPU Trial Design Poster Presented at World Conference of Lung Cancer Singapore 2020

OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTI), today announced that the lead investigator of the…